High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
about
KASL clinical practice guidelines: management of chronic hepatitis BAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.Characteristics of chronic hepatitis B patients who underwent liver biopsies.Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALTAge as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferaseHBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Parameters associated with significant liver histological changes in patients with chronic hepatitis B.Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.Nucleos(t)ide Analogue Treatment for Adult Patients with HBeAg-positive Chronic Infection with Genotype C Hepatitis B Virus: A Nationwide Real-life Study.Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels.Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
P2860
Q26752475-67168B17-29C6-4706-B93D-9ACD872F40E1Q30391932-7D5A2B43-CBE0-47A9-9324-8B4472F5D248Q33718958-BBB921B7-EA64-4AA8-A9E0-12FC6BB3BA31Q34084062-7DF27A12-8592-44BC-A8D4-660EDAFD6DE3Q34168465-8119734B-EB15-4B2C-B30A-CD4D8A45BF90Q34184642-8AC1C624-B20D-4E38-9FAC-42C503AEA398Q34365464-D657A5EE-97CB-464E-8859-95F824B97435Q34414362-61C9E3F4-C316-4899-A26F-CEF388472538Q35036631-185D0068-261E-447F-B741-6A36D155F74DQ35464781-CEFF1A22-EDE1-4B91-800C-B48DA2915A17Q35706571-AEE35C36-089D-4FB0-AE93-DB57A907CD06Q36153966-EADAEF12-CBA8-4BE7-84A7-A22AF0C94AF3Q37590449-E5C846EC-2B12-4AD3-88F0-1E56101E378EQ38175460-057730D3-545B-4C2F-B1B6-AF733FC016F0Q38689700-1A19C188-E99E-4CA5-ACB5-D6E31EB47CE0Q42198659-0D4EF1C1-1700-4845-8513-480A2B46A353Q44170366-EE5C0C40-AB52-487E-B4EC-0569853BC2A3Q45326396-9D30ECCC-AE93-40E8-9AA4-D47D5F30FC8CQ45372199-42A8918E-10D3-4415-8DCB-3203ADD7A11BQ45383929-4345491B-FCCC-4859-969C-362F6A8DAD7CQ46045006-235C6184-2609-46BE-B436-51616348FF2F
P2860
High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
High prevalence of significant ...... and high serum HBV DNA levels.
@en
type
label
High prevalence of significant ...... and high serum HBV DNA levels.
@en
prefLabel
High prevalence of significant ...... and high serum HBV DNA levels.
@en
P2093
P2860
P1476
High prevalence of significant ...... and high serum HBV DNA levels.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2893.2008.00989.X
P577
2008-06-28T00:00:00Z